Shockwave Medical
SWAV
SWAV was delisted on the 30th of May, 2024.
413 hedge funds and large institutions have $6.66B invested in Shockwave Medical in 2022 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 158 increasing their positions, 145 reducing their positions, and 56 closing their positions.
89% more call options, than puts
Call options by funds: $58M | Put options by funds: $30.7M
9% more repeat investments, than reductions
Existing positions increased: 158 | Existing positions reduced: 145
1% more funds holding
Funds holding: 409 → 413 (+4)
2% less first-time investments, than exits
New positions opened: 55 | Existing positions closed: 56
2.75% less ownership
Funds ownership: 92.42% → 89.67% (-2.8%)
22% less capital inflows, than outflows
Capital inflows: $697M | Capital outflows: $889M
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$109M |
| 2 |
Millennium Management
New York
|
+$75.8M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$50.5M |
| 4 |
BlackRock
New York
|
+$43.6M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$41.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$198M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$86.9M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$52.8M |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$49.6M |
| 5 |
Fred Alger Management
New York
|
-$41.7M |
SWAV Hedge Fund Activity: Q4 2022 in Review
413 of the 6,238 institutional investors tracked by Wall St. Rank reported a position in Shockwave Medical (SWAV) for Q4 2022, worth a combined $6.66B — down 28% from $9.23B a quarter earlier.
Sellers outnumbered buyers: 56 funds closed out of SWAV and 55 opened new positions — a net loss of 1 holder — while 145 trimmed existing stakes and 158 added.
The largest buyer was Wellington Management Group, opening a new position worth an estimated $109M. The largest seller was T. Rowe Price Associates, cutting an estimated $198M.
- 413 institutional investors held Shockwave Medical (SWAV) as of Q4 2022, up from 409 in Q3 2022.
- Funds reported $6.66B of Shockwave Medical stock for Q4 2022, down 28% quarter-over-quarter.
- 55 funds opened new Shockwave Medical positions in Q4 2022 and 56 closed out, a net change of -1 holder.
- The largest Shockwave Medical buyer in Q4 2022 was Wellington Management Group, an estimated $109M added.
- The largest Shockwave Medical seller in Q4 2022 was T. Rowe Price Associates, an estimated $198M sold.
Based on aggregated 13F filings for Q4 2022.